Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP
Report ID | 193649 |
Drug Identification Number | 02244475 |
Brand name | DIPYRIDAMOLE INJECTION, USP |
Common or Proper name | DIPYRIDAMOLE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | DIPYRIDAMOLE |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 mL |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-07-01 |
Actual start date | 2023-08-23 |
Estimated end date | 2024-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-28 |
Company comments | Please be advised that this product is on 100% allocation. |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2024-03-28 | French | Compare |
v21 | 2024-03-28 | English | Compare |
v20 | 2024-03-28 | English | Compare |
v19 | 2024-02-01 | French | Compare |
v18 | 2024-02-01 | English | Compare |
v17 | 2024-01-31 | French | Compare |
v16 | 2024-01-31 | English | Compare |
v15 | 2023-11-29 | French | Compare |
v14 | 2023-11-29 | English | Compare |
v13 | 2023-10-03 | French | Compare |
v12 | 2023-10-03 | English | Compare |
v11 | 2023-08-24 | English | Compare |
v10 | 2023-08-18 | French | Compare |
v9 | 2023-08-18 | English | Compare |
v8 | 2023-07-21 | French | Compare |
v7 | 2023-07-21 | English | Compare |
v6 | 2023-07-18 | English | Compare |
v5 | 2023-07-02 | English | Compare |
v4 | 2023-06-02 | French | Compare |
v3 | 2023-06-02 | English | Compare |